Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits

Source: Financial Times [UK]

“Pfizer has agreed to pay up to $250mn to settle more than 10,000 US lawsuits over cancer risks associated with its now-discontinued heartburn drug Zantac, according to people familiar with the deal. The settlement — which was disclosed in a court filing in Delaware last week — is aimed at significantly reducing Pfizer’s potential liability. The New York-based drugmaker was set to pay plaintiffs between $200mn- $250mn to settle the cases, two people briefed on the deal said.” (05/16/24)